Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06569810
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-05
Brief Title:
Real-world Registry Study of Red Light Treatment on Myopia Control a Focus on Non-responders to Conventional Treatments
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Real-world Registry Study of Red Light Treatment on Myopia Control a Focus on Non-responders to Conventional Treatments
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This real-world observational registry study aims to assess the effectiveness of Repeated Low-Level Red Light RLRL therapy in controlling myopia progression among children aged 8 to 16 who have not responded to conventional treatments like Orthokeratology and atropine eyedrops The primary focus is to determine if RLRL therapy can limit axial length AL elongation to less than 01mm per year and spherical equivalent refraction SER progression to less than 025 diopter per year while also evaluating safety and visual outcomes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None